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Abstract
In this study, we aimed to identify characteristics of (unscheduled) revisits and its optimal time frame after Emergency
Department (ED) discharge. Children with fever, dyspnea, or vomiting/diarrhea (1 month–16 years) who attended the ED of
Erasmus MC-Sophia, Rotterdam (2010–2013), the Netherlands, were prospectively included. Three days after ED discharge, we
applied standardized telephonic questionnaires on disease course and revisits. Multivariable logistic regression analysis was used
to identify independent characteristics of revisits. Young age, parental concern, and alarming signs and symptoms (chest wall
retractions, ill appearance, clinical signs of dehydration, and tachypnea) were associated with revisits (n = 527) in children at risk
for serious infections discharged from the ED (n = 1765). Children revisited the EDwithin a median of 2 days (IQR 1.0–3.0), but
this was proven to be shorter in children with vomiting/diarrhea (1.0 day (IQR 1.0–2.0)) compared to children with fever or
dyspnea (2.0 (IQR 1.0–3.0)).
Conclusion: Young age, parental concern, and alarming signs and symptoms (chest wall retractions, ill appearance, clinical
signs of dehydration, and tachypnea) were associated with emergency health care revisits in children with fever, dyspnea, and
vomiting/diarrhea. These characteristics could help to define targeted review of children during post-discharge period. We
observed a disease specific and differential timing of control revisits after ED discharge.
What is Known
• Fever, dyspnea, and vomiting/diarrhea are major causes of emergency care attendance in children.
• As uncertainty remains on uneventful recovery, patients at risk need to be identified on order to improve safety netting after discharge from the ED.
What is New
• In children with fever, dyspnea, and vomiting/diarrhea, young age, parental concern and chest wall retractions, ill appearance, clinical signs of
dehydration, and tachypnea help to define targeted review of children during the post-discharge period.
• A revisit after ED discharge is disease-specific and seems to be shorter for children with vomiting/diarrhea than others.
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Introduction
Fever, dyspnea, and vomiting/diarrhea are major causes of
emergency care attendance in childhood. Serious infections
(SI) could be the underlying cause of these symptoms.
Morbidity and mortality after Emergency Department (ED)
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Characteristics of revisits of children at risk for serious infections
in pediatric emergency care
visit due to serious infections or a complicated disease course
of a self-limiting viral illness should not be underestimated.
Infections account for 20% of childhood deaths in England,
Wales, and Northern Ireland, with the greatest number in chil-
dren aged 1–4 years [11, 14]. In the Netherlands, between
1969 and 2006, mortality due to infectious diseases compared
to total childhood mortality was around 3.0% [22].
Serious infections are mostly defined as sepsis (including
bacteremia), meningitis, pneumonia, osteomyelitis, cellulitis,
gastroenteritis with severe dehydration, complicated urinary
tract infection (positive urine culture and systemic effects such
as fever), and viral respiratory tract infections complicated by
hypoxia (e.g., bronchiolitis) [18]. At the ED, serious infec-
tions can be hard to recognize, as they can present similar to
a self-limiting (viral) disease during early presentation, even-
tually leading to a diagnostic or treatment delay.
Dealing with this uncertainty on diagnosis or disease
course after ED discharge, clinicians usually schedule revisits
in a substantial number of cases. In addition, they provide
parents with instructions on expected disease course, alarming
signs and symptoms, and when to revisit, a well-known con-
cept called Bsafety netting^ [1, 16].
A recent systematic review concluded that studies
concerning effects of safety netting interventions were mostly
conflicting or with limited evidence [7]. They described
strong associated characteristics of revisits as young children,
infectious/respiratory symptoms, and progression of symp-
toms. However, evidence on follow-up management and its
time frame as a part of the whole process of safety netting in
children at risk for serious infections is lacking [10].
To improve the process of safety netting, we aimed to iden-
tify characteristics of (unscheduled) revisits and the timing of
these revisits in a prospectively collected cohort of children
with fever, vomiting/diarrhea, or dyspnea, discharged from
the ED.
Methods
Study design and setting
We conducted a prospective follow-up study at the ED of the
Erasmus MC-Sophia Children’s Hospital in Rotterdam. This
large inner-city university hospital is visited annually by near-
ly 7000 childrenwith a mixed ethnic population of which 35%
have chronic comorbidity.
Participants
We prospectively enrolled all consecutive children (≥
1 month–< 16 years) attending the ED with fever, vomiting/
diarrhea, or dyspnea from March 2010 to October 2013.
Febrile children were defined as eligible if fever had been
noted at home in the 24 h prior to presentation, when body
temperature measured at the ED was ≥38.5 °C or fever was
used as a positive discriminator of the Manchester Triage
System (MTS) [6]. Children with vomiting/diarrhea needed
to be suspected of a recent infectious cause. To be included,
the illness episode had to be preceded by a minimum symp-
tom free period of 2 weeks and the illness episode needed to
be related to an infectious disease. Children were assigned to
dyspnea when respiratory complaints, with or without
bronchoconstriction, were the main reason of visiting the
ED. Children with dyspnea who also suffered from fever were
assigned to dyspnea if these symptoms took precedence over
fever-related complaints. Given the aim of the study, i.e., im-
proving discharge advice, we excluded children who were
admitted to the hospital ward after initial ED visit. Next, as
children with a known medical history or medical diagnosis
get specific safety netting advice for their chronic condition in
their outpatient follow-up (by pediatrician and specialist
nurse), they are another population compared to the children
with common acute illnesses at the ED. As children with a
known medical history or medical diagnosis may be managed
differently at ED or by (experienced) parents, we excluded
children with complex needs as well as children with
predefined asthma [24].
Revisit
Data collection
All children who attended the ED were routinely triaged with
the MTS. This digital recorded triage system is used to prior-
itize patients according to acuity [21]. In the analysis, MTS
categories were reformatted into three categories: (1)
emergent/very urgent, (2) urgent, and (3) non-urgent/standard
to guarantee sufficient numbers per category. We collected
patient characteristics from a structured electronic patient re-
cord system (gender, age, reason of ED visit, visit date, triage
information), referral profile, duration of the complaints, clin-
ical signs and symptoms, observations, and measures from
physical examination (e.g., vital signs, temperature, breathing
difficulty, clinical appearance) [13, 20, 24].
During the process of discharge, patients received informa-
tion on alarming signs and symptoms, expected disease
course, and on when and how to return. Part of the children
received a scheduled revisit, by judgment of the attending
physician, based on either the clinical signs and symptoms
or expected complications, or on parental concern. In addition
to these scheduled revisits (i.e., initiated/appointed by the phy-
sician at discharge), patients could revisit unscheduled (i.e.,
patient-initiated). These data were collected using a standard-
ized telephonic questionnaire on the disease course which
parents were asked to answer 3 days after ED discharge. The
questionnaire included specifically data on duration or reoc-
currence of symptoms as well as on complications, and on
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revisits to the hospital ED, to primary care, or to other health
care settings. When the child was not yet fully recovered, we
continued our follow-up by telephone until complete remis-
sion of their symptoms.
Outcome measures and definitions
Our primary outcome measures were (1) revisits, defined as
all revisits occurring for the same health care problem at either
the GP (primary care) and the emergency department (second-
ary care) after the first ED visit, and (2) the time until this
revisit, measured as the time gap between discharge and re-
visit. Secondary outcome measures included unscheduled re-
visits (defined as an unplanned control visits after the initial
visit) and hospitalization following a revisit.
To evaluate parental concern, parents were asked if they
considered their child’s illness at initial ED revisit to be dif-
ferent from earlier episodes. This is in accordance with
previous studies in primary care, showing that parental con-
cern is an important determinant of serious infections [17, 18].
Ethics
Ethical approval was obtained from the institutional review
board (IRB) of the Erasmus MC (MEC-2005-314).
Informed consent was required and obtained from all parents.
Statistical analysis
Variable selection
Variable selection for studying potential characteristics of re-
visits were based on previously published decision models or
risk scores [2, 3, 8] and a recent systematic review on charac-
teristics of pediatric health care revisits (Table 1) [10].
Table 1 Variable selection
according to decision model, risk
scores, and systematic review
Feverkidstool
[13]
Friedman dehydration
score [9]
Indicators of
dyspnea [15]
Systematic
review [7]
Child characteristics
Age X X
Gender X
Ill appearance X X
Characteristics general
Tachycardia X
Prolonged cap. Refill time X
Relevant medical history X
Infectious/respiratory
symptoms
X
Seizures X
Progression/persistence
of symptoms
X
CRP bedside (ln) X
Characteristics of fever
Duration of fever X
Temperature (°C) X
Characteristics of dehydration
Eyes X
Dry mucosa X
Tears X
Vomiting
Characteristics of dyspnea
Dyspnea X
Chestwall retractions X X
Decreased oxygen
saturation
X X
Tachypnea X X
Auscultation X
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Characteristics of revisits
Since patients with fever, vomiting/diarrhea, or dyspnea may
differ in their disease course and time frame, we performed
analysis separately for each of these patient groups. Time until
ED revisit was evaluated by Kaplan-Meier survival analysis.
Previous research in our setting showed that 12% of all
discharged children underwent revisits of which 4% included
interventions [4]. To analyze 10–15 characteristics of revisits,
it was decided that we should have at least 10 times as many
events (100–150 revisits) [4, 5]. With these distributions, we
estimated to include at least around 830 (100/0.12) to 1250
(150/0.12) children.
Missing values
To allow optimal use of available data in multivariate models,
missing data were imputed 10 times using a multiple imputa-
tion process with the mice algorithm in R software (version
3.0) under the assumption to be missing at random [26]. The
imputation model included all variables which were consid-
ered in the multivariable logistic regression analysis, the out-
come variable (revisits), and several relevant variables de-
scribing case mix of the patients (e.g., gender and MTS ur-
gency) (Tables S1, and S2.1, S2.2, S2.3). All analyses, except
for multiple imputation, were performed with SPSS software
(version 20.0, SPSS Inc., Chicago).
Results
Successful follow-up by telephone was achieved for 1765
children, encompassing 80% of the total eligible population
(n = 2214) (Fig. 1). Overall patients’ median age was
22 months (IQR 11–48), with 57% boys (n = 1000). The re-
visit rate was 30% (n = 527) and 3% (n = 54) of the children
were hospitalized after revisiting the ED (Table 2). Most chil-
dren were triaged as urgent patients (54%; n = 944) and 51%
were referred by physicians.
Febrile children constituted 64% (n = 1136) of included
children, with 346 (n = 31%) revisits. Twenty-one percent
(n = 372) children suffered from vomiting/diarrhea with 108
(29%) revisits. Fifteen percent (n = 257) of all children had
dyspnea, with 73 (n = 28%) revisits.
Characteristics of revisits overall
Out of 527 revisits, 352 (67%) revisits were unscheduled
(Table 3). The number of unscheduled revisits was the lowest
for children with vomiting/diarrhea (n = 57, 15.3%) and the
highest for children with dyspnea (n = 55, 21.4%) (Table 3).
Children revisited the ED after a median of 2 days (IQR
1.0–3.0). Children with vomiting/diarrhea revisited the ED
significantly at a shorter interval (1.0 day (IQR 1.0–2.0)) than
children with fever or dyspnea (2.0 (IQR 1.0–3.0)) (log rank
p < 0.0001).
Characteristics of revisits of febrile children
Age, parental concern, and chest wall retractions were
associated with revisits in febrile children (multivariable
ORs between 1.30–1.98) (p value < 0.1) (Table 4). Young
age and parental concern, in particular, were associated
with unscheduled revisits (respectively, OR (CI 95%)
1.42 (1.04–1.95) and OR (CI 95%) 1.81 (1.13–2.90))
(Table 4).
Characteristics of revisits of children
with vomiting/diarrhea
The characteristics age < 1 year, ill appearance, clinical signs
of dehydration at initial assessment, and tachypnea were asso-
ciated with revisits (p value < 0.10) (Table 4). Age and
tachypnea remained strongly independent associated with un-
scheduled revisits (Table 4).
Successful contacted population
(n=1812; 82%)
Not reached by telephone/ 
no questionnaire returned 
(n=402; 18%)
Final included population  
(n=1765; 80%)
No informed consent
(n=47; 2%)
Total eligible population  
(n=2214; 100%)
Fig. 1 Patient flowchart
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Table 2 Demographics of total population
Presenting problem, n (%)
Total, n = 1765 (100) Fever, n = 1136 (64.4) Vomiting/diarrhea, n = 372 (21.1) Dyspnea, n = 257 (14.5)
Sex, malea 1000 (56.7)* 635 (55.9) 194 (52.2) 171 (66.5)
Age (months)b 22.0 (11.0–48.0)* 23.0 (12.0–51.0) 18.0 (9.0–41.0) 21.0 (8.0–41.0)
All revisitsa 527 (29.9) 346 (30.5) 108 (29.0) 73 (28.4)
Unscheduled revisita 352 (19.9)* 240 (21.1) 57 (15.3) 55 (21.4)
Secondary hospitalization 54 (3.1) 28 (2.5) 17 (4.6) 9 (3.5)
Parental concern 1410 (79.9)* 952 (83.8) 285 (76.6) 173 (67.3)
MTS urgency initial ED visit
Emergent/very urgent 331 (18.7)* 203 (17.9) 34 (9.1) 94 (36.6)
Urgent 944 (53.5)* 700 (61.6) 161(43.3) 83 (32.3)
Standard/non-urgent 490 (27.8)* 233 (20.5) 177 (47.6) 80 (31.1)
Type of referred initial ED visit
Self-referral 865 (49.0)* 547 (48.2) 216 (58.1) 102 (39.7)
Physicianc 900 (51.0)* 589 (51.8) 156 (41.9) 155 (60.3)
*P value < 0.05
a Absolute number (percentage)
bMedian (IQR)
c Including primary, secondary, and ambulance care
Table 3 Characteristics of revisits
Presenting problem, n (%)
Total,
n = 527/1765 (29.9)
Fever,
n = 346/1136 (30.5)
Vomiting/diarrhea,
n = 108/372 (29.0)
Dyspnea,
n = 73/257 (28.4)
Revisits with interventiona 293 (55.6)d 199 (57.5) 47 (43.5) 47 (64.4)
Unscheduleda 352 (66.8)d 240 (69.4) 57 (52.8) 55 (75.3)
Time until revisit (days)b 2.0 (1.0–3.0) 2.0 (1.0–3.0) 1.0 (1.0–2.0) 2.0 (1.0–4.0)c
Time until unscheduled revisit 3.0 (2.8–3.2) 2.0 (1.7–2.3) 2.0 (1.4–2.6) 3.0 (2.4–3.6)
Setting of revisit
Primary care 249 (47.2) 180 (52.0) 35 (32.4) 34 (46.6)
Emergency care 278 (52.8) 166 (48.0) 73 (67.6) 39 (53.4)
a Absolute number (percentage)
bMedian (IQR)
c Log rank < 0.000
dP value < 0.05:
- More revisits with intervention in febrile children versus children with vomiting/diarrhea (chi-square)
- More unscheduled revisits in febrile children versus children with vomiting/diarrhea (chi-square)
- More prescribed antibiotics in febrile children versus children with vomiting/diarrhea and children with dyspnea (chi-square)
- More prescribed airway medicine in children with dyspnea versus febrile children and children with vomiting/diarrhea (chi-square)
- More prescribed gastro-intestinal medicine in children with vomiting/diarrhea versus febrile children and children with dyspnea (chi-square)
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Characteristics of revisits of children with dyspnea
In children with dyspnea, we could only identify the determi-
nant Bage < 3 years^ to be significantly associated with re-
visits (p value < 0.10) (Table 4).
Discussion
Main findings
In a prospectively study on clinical symptoms and signs that
are associated with health care revisits in children with fever,
dyspnea, and vomiting/diarrhea, we observed young age, pa-
rental concern, and alarming signs and symptoms (chest wall
retractions, ill appearance, clinical signs of dehydration, and
tachypnea) to be the most important. Children with vomiting/
diarrhea revisited the ED at a shorter interval (median 1 day;
IQR 1.0–2.0) compared with children with fever or dyspnea
(median 2 days; IQR 1.0–4.0).
Clinical implications and comparison with other
studies
In order to optimize the process of safety netting, we prospec-
tively evaluated characteristics of revisits in children at risk for
serious infections discharged from the ED, originating from
the question on which children need revisits and in what time
frame. Although we identified various characteristics, they do
not select a definite population that will not (need to) revisit
the ED.
In summary, there is a need for safety netting in all children
after discharge from the ED, however, with special attention
for a subgroup of children at risk with young age, parental
concern, and specific symptoms and signs. Our results support
specific time frames for specific presenting conditions.
Strengths and limitations
The major strength of this prospective study is the large num-
ber of children with complete follow-up, as we included up to
80% of the eligible children successfully in our study. Second,
our study did not only include revisits to our hospital ED, but
also to other EDs in the area as well as revisits to primary care
or other emergency care settings.
Lastly, we studied the role of parental concern in the emer-
gency care setting [17, 18]. We found an association between
parental concern and revisits only in the group of febrile chil-
dren. In the majority of affirmative answers, parental concern
was caused by a longer duration or a more severe illness. It is
important to remark this indicator of a probable complicated
clinical course, as it emphasizes the meaningful role of parents
in the assessment of their child’s illness in secondary care
settings in addition to the known role in primary care [18].
This study has some limitations. In our study, we chose
revisits as our primary outcome measure and we separately
analyzed unscheduled revisits. As former research showed the
following risk factors for pediatric ED revisits: arrival in the
evening, respiratory diagnosis, and acute triage category [19],
onemight argue that our secondary outcome, i.e., unscheduled
revisit and hospitalization, would be of more clinical rele-
vance. However, unscheduled revisits can be influenced by
the clinical setting and by the time frame the scheduled revisit
was originally planned in, and also would be related to paren-
tal background and concepts of disease and their uncertainty
or comprehension ability to understand provided information.
There are several factors, influencing the attending physi-
cian’s decision to schedule a follow-up appointment or to
admit a patient, besides having to perform further diagnostic
tests or treatment. We observed 293/527 (55.6%) visits with
an intervention (defined as diagnostics, treatment, or admis-
sion) (Table 3). Admission occurred in 54 (10.2%) patients.
In all other revisits (234/527; 44.4%) patients did not re-
ceive any diagnostics or treatment, nor were they admitted to
Table 4 Determinants of revisits
in children with fever, vomiting/
diarrhea, and dyspnea
Determinants Revisits, n = 346 Unscheduled revisits, n = 240
Fever OR (95% CI) OR (95% CI)
Age < 1 year 1.30 (0.98–1.72)* 1.42 (1.04–1.95)**
Parental concern 1.71 (1.15–2.55)** 1.81 (1.13–2.90)**
Chestwall retractions 1.98 (1.02–3.82)** 1.68 (0.82–3.44)
Vomiting/diarrhea n = 108 n = 57
Age < 1 year 1.87 (1.14–3.07)** 2.09 (1.15–3.80)**
Ill appearance 1.91 (1.03–3.53)** 1.29 (0.58–2.85)
Clinical signs of dehydration 2.26 (1.12–4.53)** 1.96 (0.85–4.54)
Tachypnea 5.08 (2.30–11.25)** 4.12 (1.59–10.69)**
Any sign of dyspnea n = 73 n = 55
Age < 3 year 0.58 (0.31–1.09)* 0.58 (0.28–1.17)
*Significant predictors (p < 0.10), **significant predictors (p < 0.05)
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the hospital. However, to regard them just as a Breassurance^-
revisit for parents would be too simplistic, as other factors like
alarming signs, gut feeling, and experience of the attending
physician can influence this decision. We can only speculate
about the reasons as detailed information is missing, and this
topic was beyond the scope of our study.
Selection bias and recall bias are well-known problems of
questionnaire studies [12, 23]. However, our study reached a
high response rate of 80%, in contrast to most response rates
of telephonic or postal questionnaire studies of less than 60%
[25]. Recall bias may especially have influenced the subjec-
tive determinant parental concern. However, as parents were
called only 3 days after ED discharge, this should be less of a
problem in our study.
Conclusion
In this prospective cohort study on ED patients, we observed
young age, parental concern, and alarming signs and symp-
toms (chest wall retractions, ill appearance, clinical signs of
dehydration, and tachypnea) being associated with emergency
health care revisits in children with fever, dyspnea, and
vomiting/diarrhea. In addition to the general need for safety
netting procedures in children at risk for serious infections,
these characteristics could help to define targeted review of
children during post-discharge period. A control visit after ED
discharge is disease-specific, and the post-discharge interval
seems to be shorter for children with vomiting/diarrhea than
others in particular.
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